Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 11.89 |
|---|---|
| High | 12.50 |
| Low | 11.79 |
| Bid | 12.39 |
| Offer | 12.57 |
| Previous close | 11.99 |
| Average volume | 2.78k |
|---|---|
| Shares outstanding | 183.70m |
| Free float | 179.94m |
| P/E (TTM) | 7.76 |
| Market cap | 2.61bn USD |
| EPS (TTM) | 1.83 USD |
| Annual div (ADY) | 1.59 EUR |
|---|---|
| Annual div yield (ADY) | 13.27% |
| Div ex-date | Feb 25 2026 |
| Div pay-date | Mar 04 2026 |
Data delayed at least 15 minutes, as of Mar 02 2026 18:30 GMT.
More ▼
Press releases
- Hercules Capital Named 2025 Americas BDC Manager of the Year by Private Debt Investor
- Hercules Capital Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hercules Capital Closes Institutional Notes Offering of $300.0 Million 5.350% Unsecured Notes due 2029
- Hercules Capital Announces New Supplemental Cash Distribution of $0.28 per Share
- Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Fourth Quarter 2025
- Hercules Capital Prices Institutional Notes Offering of $300.0 Million 5.350% Notes due 2029
- Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call
- Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
- enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
- Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
More ▼
